Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$0.21.

  • Gossamer Bio's EPS (Basic) fell 5000.0% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.69, marking a year-over-year decrease of 16538.46%. This contributed to the annual value of -$0.25 for FY2024, which is 7882.44% up from last year.
  • Gossamer Bio's EPS (Basic) amounted to -$0.21 in Q3 2025, which was down 5000.0% from -$0.17 recorded in Q2 2025.
  • Gossamer Bio's EPS (Basic)'s 5-year high stood at $0.22 during Q2 2024, with a 5-year trough of -$0.76 in Q1 2022.
  • For the 4-year period, Gossamer Bio's EPS (Basic) averaged around -$0.32, with its median value being -$0.21 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 14888.89% in 2024, then plummeted by 17727.27% in 2025.
  • Over the past 4 years, Gossamer Bio's EPS (Basic) (Quarter) stood at -$0.57 in 2022, then surged by 73.68% to -$0.15 in 2023, then grew by 2.67% to -$0.15 in 2024, then crashed by 43.84% to -$0.21 in 2025.
  • Its EPS (Basic) stands at -$0.21 for Q3 2025, versus -$0.17 for Q2 2025 and -$0.16 for Q1 2025.